P1279: OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA WITH TWO OR MORE HIGH-RISK CYTOGENETIC ABNORMALITIES

• Oren Pasvolsky,
• Sassine Ghanem,
• Denái R. Milton,
• Adeel Masood,
• Mark R. Tanner,
• Qaiser Bashir,
• Samer Srour,
• Neeraj Saini,
• Jeremy L. Ramdial,
• Yago Nieto,
• Hans C. Lee,
• Krina K. Patel,
• Partow Kebriaei,
• Sheeba K. Thomas,
• Donna M. Weber,
• Robert Z. Orlowski,
• Elizabeth J. Shpall,
• Richard E. Champlin,
• Muzaffar H. Qazilbash

Affiliations

Oren Pasvolsky

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Sassine Ghanem

4 Alpert Medical School of Brown University, Department of Medicine, Providence, United States

Denái R. Milton

5 The University of Texas MD Anderson Cancer Center, Department of Biostatistics, Houston, United States

Adeel Masood

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Mark R. Tanner

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Qaiser Bashir

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Samer Srour

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Neeraj Saini

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Jeremy L. Ramdial

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Yago Nieto

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Hans C. Lee

6 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Krina K. Patel

6 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Partow Kebriaei

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Sheeba K. Thomas

6 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Donna M. Weber

6 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Robert Z. Orlowski

6 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Elizabeth J. Shpall

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Richard E. Champlin

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Muzaffar H. Qazilbash

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States